Anika Therapeutics (ANIK) Tops Q2 EPS by 35c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Barrington Research Upgrades Anika Therapeutics (ANIk) to Outperform
July 27, 2018 8:29 AM EDTBarrington Research upgraded Anika Therapeutics (NASDAQ: ANIk) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Anika Therapeutics click here. For more ratings news on Anika Therapeutics click here.
Shares of Anika Therapeutics closed at $40.68 yesterday.
... More